4ANTIBODY AG has a total of 36 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), China and Israel. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SCIL PROTEINS GMBH, NBE THERAPEUTICS LLC and HUALAN BIOLOGICAL ENG CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | China | 4 | |
#3 | Israel | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Singapore | 3 | |
#6 | Canada | 2 | |
#7 | Hong Kong | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Mexico | 2 | |
#10 | New Zealand | 2 | |
#11 | United States | 2 | |
#12 | Colombia | 1 | |
#13 | Japan | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Grawunder Ulf | 23 |
#2 | Winkler Thomas | 10 |
#3 | Spindler Nadja | 10 |
#4 | Mach Michael | 10 |
#5 | Sticht Heinrich | 9 |
#6 | Martin-Parras Luis | 8 |
#7 | Wiegers Anna-Katharina | 8 |
#8 | Stitz Joern | 5 |
#9 | Poetzsch Sonja | 5 |
#10 | Melchers Georg Friedrich | 5 |
Publication | Filing date | Title |
---|---|---|
CN102892782A | Binding members for human cytomegalovirus | |
EP2325322A1 | Retroviral vector particles and methods for their generation and use | |
EP2098536A1 | Isolation and identification of antigen- or ligand-specific binding proteins | |
ZA200403978B | Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins. | |
EP1321477A1 | Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins | |
US2006052585A1 | Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |